story of the week
Donanemab Shows Promise in Early Alzheimer Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Donanemab in Early Alzheimer’s Disease
N. Engl. J. Med 2021 Mar 13;[EPub Ahead of Print], MA Mintun, AC Lo, C Duggan Evans, AM Wessels, PA Ardayfio, SW Andersen, S Shcherbinin, J Sparks, JR Sims, M Brys, LG Apostolova, SP Salloway, DM SkovronskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.